It was two years ago that Novartis and Google combined research and development efforts to develop two versions of their smart contact lenses. According to Novartis Chief Executive Joe Jimenez, the company Alcon eye care unit was supposed to begin clinical trials this year.
According to VentureBeat, one version of the smart contacts would be autofocusing for people with presbyopia (far-sightedness) and the other would be for measuring blood glucose levels in diabetes patients (no more needles).
Photo Source: Google
In an email on Friday, a spokewoman for Novartis sent an email stating, “It is too early to say when exactly human clinical trials for these lenses will begin,”
The Google Smart Contact Lens operates using a wireless chip and a miniature glucose sensor that takes it measurements from your tears. The electronics are inserted between two layers of soft lens material. There may be tiny LEDs down the line, which will alert users when their glucose levels reach certain boundaries.